Yosuke Mai Wataru Nishie Kazumasa Sato Moeko Hotta Kentaro Izumi Kei Ito Kazuyoshi Hosokawa Hiroshi Shimizu
10.3389/fimmu.2018.00542
Front Immunol
2018 Apr 12;9:542.
autoantibodies autoimmune disease bullous pemphigoid burn cellulitis dipeptidyl peptidase-iv inhibitor dipeptidyl peptidase-iv inhibitor-associated bullous pemphigoid physical factors
CC BY
https://pubmed.ncbi.nlm.nih.gov/29706950/
Burns / complications Diabetes Mellitus, Type 2 / drug therapy Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / adverse effects Linagliptin / adverse effects Pemphigoid, Bullous / chemically induced
Burns / complications Diabetes Mellitus, Type 2 / drug therapy Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / adverse effects Linagliptin / adverse effects Pemphigoid, Bullous / chemically induced Case Reports Research Support, Non-U.S. Gov't Review Humans Male Middle Aged Linagliptin Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
PMC5906537
29706950
Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature
2018